Efficacy and Safety of TurmXTRA® 60N in Delayed-onset Muscle Soreness in Healthy, Recreationally Active Subjects: a Randomized, Double-blind, Placebo-controlled Trial

Shefali Thanawala, Rajat Shah, Vasu Karlapudi, Prabakaran Desomayanandam, Arun Bhuvanendran
doi: https://doi.org/10.1101/2022.05.10.22274831

Article Information

doi 
https://doi.org/10.1101/2022.05.10.22274831
History 
  • May 17, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Shefali Thanawala1,*,
  2. Rajat Shah1,
  3. Vasu Karlapudi2,
  4. Prabakaran Desomayanandam3 and
  5. Arun Bhuvanendran3
  1. 1Nutriventia, Inventia Healthcare Ltd., Mumbai, India
  2. 2Pujitha Hospital, Vijayawada, India
  3. 3In Vitro Research Solutions (iVRS) Pvt Ltd, Bengaluru, India
  1. ↵*Corresponding author:
    Dr. Shefali Thanawala, Nutriventia, Inventia Healthcare Ltd., Mumbai, India, Email id: Shefali.thanawala{at}inventiahealthcare.com, Contact number: +912267163280
Back to top
Posted May 17, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Efficacy and Safety of TurmXTRA® 60N in Delayed-onset Muscle Soreness in Healthy, Recreationally Active Subjects: a Randomized, Double-blind, Placebo-controlled Trial
Shefali Thanawala, Rajat Shah, Vasu Karlapudi, Prabakaran Desomayanandam, Arun Bhuvanendran
medRxiv 2022.05.10.22274831; doi: https://doi.org/10.1101/2022.05.10.22274831
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area